Dr. Danyaal Moin, M.D
NPI: 1962729384
Total Payments
$4,819
2024 Payments
$751.93
Companies
22
Transactions
156
Medicare Patients
1,324
Medicare Billing
$267,578
Payment Breakdown by Category
Food & Beverage$3,944 (81.8%)
Travel$816.44 (16.9%)
Education$36.70 (0.8%)
Other$21.96 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,944 | 145 | 81.8% |
| Travel and Lodging | $816.44 | 4 | 16.9% |
| Education | $36.70 | 6 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21.96 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,459 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,024 | 63 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $307.80 | 9 | $0 (2024) |
| Daiichi Sankyo Inc. | $130.20 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $109.44 | 4 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $95.13 | 4 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $89.40 | 1 | $0 (2017) |
| PFIZER INC. | $73.85 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $71.14 | 3 | $0 (2024) |
| United Therapeutics Corporation | $70.53 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $751.93 | 29 | Alnylam Pharmaceuticals Inc. ($281.05) |
| 2023 | $548.01 | 15 | Abbott Laboratories ($225.27) |
| 2022 | $249.15 | 6 | Abbott Laboratories ($156.34) |
| 2021 | $38.56 | 6 | Abbott Laboratories ($23.56) |
| 2020 | $92.65 | 6 | Novartis Pharmaceuticals Corporation ($71.44) |
| 2019 | $715.93 | 39 | Novartis Pharmaceuticals Corporation ($455.20) |
| 2018 | $847.39 | 37 | Novartis Pharmaceuticals Corporation ($431.97) |
| 2017 | $1,576 | 18 | Abbott Laboratories ($1,415) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: DIABETES | ||||||
| 11/27/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $39.27 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.32 | General |
| Category: Cardiovascular | ||||||
| 10/07/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Heart Failure | ||||||
| 10/01/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $149.39 | General |
| 08/29/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Heart Failure | ||||||
| 08/22/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Genetic Disease | ||||||
| 08/22/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: Genetic Disease | ||||||
| 07/31/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.41 | General |
| 07/24/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Heart Failure | ||||||
| 07/17/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.83 | General |
| 07/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: Heart Failure | ||||||
| 07/15/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $33.73 | General |
| Category: Genetic Disease | ||||||
| 07/09/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.57 | General |
| 07/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: Genetic Disease | ||||||
| 05/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.35 | General |
| 05/17/2024 | One Lambda, Inc. | — | Food and Beverage | Cash or cash equivalent | $33.64 | General |
| 05/01/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/05/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $13.69 | General |
| Category: Coronary | ||||||
| 03/21/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.32 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 348 | 637 | $482,427 | $70,843 |
| 2022 | 8 | 301 | 798 | $522,323 | $74,463 |
| 2021 | 7 | 352 | 910 | $576,044 | $76,086 |
| 2020 | 7 | 323 | 622 | $146,745 | $46,186 |
Total Patients
1,324
Total Services
2,967
Medicare Billing
$267,578
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 90 | 216 | $154,440 | $23,065 | 14.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 66 | $93,390 | $12,666 | 13.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 54 | 55 | $77,880 | $8,602 | 11.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 105 | $54,495 | $7,508 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 60 | $33,000 | $7,004 | 21.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 39 | $29,055 | $6,197 | 21.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 18 | $13,410 | $2,293 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $10,967 | $1,521 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 15 | $8,250 | $1,302 | 15.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 52 | $7,540 | $685.72 | 9.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 76 | 319 | $174,592 | $27,896 | 16.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 20 | 105 | $153,003 | $19,328 | 12.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 43 | 49 | $51,492 | $8,342 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 56 | $40,520 | $5,999 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 45 | 57 | $32,034 | $4,653 | 14.5% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 13 | 136 | $40,504 | $4,448 | 11.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 41 | $18,677 | $2,050 | 11.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $10,220 | $1,629 | 15.9% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 21 | 21 | $1,281 | $117.84 | 9.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 63 | 280 | $192,640 | $25,514 | 13.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 152 | $111,872 | $17,319 | 15.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 61 | 67 | $89,512 | $11,841 | 13.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 59 | 182 | $86,814 | $11,541 | 13.3% |
| 93750 | Evaluation of lower heart chamber assist device with physician analysis | Facility | 2021 | 12 | 150 | $58,200 | $5,229 | 9.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $25,415 | $3,363 | 13.2% |
About Dr. Danyaal Moin, M.D
Dr. Danyaal Moin, M.D is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1962729384.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danyaal Moin, M.D has received a total of $4,819 in payments from pharmaceutical and medical device companies, with $751.93 received in 2024. These payments were reported across 156 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,944).
As a Medicare-enrolled provider, Moin has provided services to 1,324 Medicare beneficiaries, totaling 2,967 services with total Medicare billing of $267,578. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Brooklyn, NY
- Active Since 04/25/2010
- Last Updated 04/24/2024
- Taxonomy Code 207RA0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962729384
Products in Payments
- Circulatory Support (Device) $1,270
- ENTRESTO (Drug) $996.71
- CardioMEMS HF System (Device) $617.50
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $353.05
- INJECTAFER (Drug) $130.20
- CAMZYOS (Drug) $109.44
- AMVUTTRA (Drug) $97.93
- CARDIOMEMS (Device) $91.87
- LifeVest (Device) $89.40
- HeartMate (Device) $82.42
- VYNDAQEL (Drug) $73.85
- JARDIANCE (Drug) $71.14
- ORENITRAM (Drug) $60.53
- ONPATTRO (Drug) $60.48
- ZIO XT Patch (Device) $56.63
- TEGSEDI (Drug) $48.31
- HeartMate Touch (Device) $44.13
- AccuCinch (Device) $39.27
- LOKELMA (Drug) $37.82
- LEQVIO (Drug) $27.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in Brooklyn
Norbert Moskovits, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $327,637
Advanced Heart Failure and Transplant Cardiology $327,637
Dr. Steven Sorci, Do, DO
Advanced Heart Failure and Transplant Cardiology — Payments: $14,116
Advanced Heart Failure and Transplant Cardiology $14,116